Evidence map›Paper›PMID 37488288›Full record

ArticleNature medicine2023

Pig-to-human heart xenotransplantation in two recently deceased human recipients.

Nader Moazami, Jeffrey M Stern, Karen Khalil, Jacqueline I Kim, Navneet Narula, Massimo Mangiola, Elaina P Weldon, Larisa Kagermazova, Les James, Nikki Lawson and 33 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
51.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed, 163 citations in OpenAlex.

  1. Article
  2. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Targeting Arterial Dysfunction in Cardiovascular Disease Using Stem Cell-Based Therapies.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

43 authors at 5 institutions in 1 country.

Nader MoazamiDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA. nader.moazami@nyulangone.org.ORCID http://orcid.org/0000-0001-5306-070X
Jeffrey M SternNew York University Langone Transplant Institute, New York, NY, USA.ORCID http://orcid.org/0000-0001-5588-0357
Karen KhalilNew York University Langone Transplant Institute, New York, NY, USA.ORCID http://orcid.org/0000-0001-7350-0418
Jacqueline I KimNew York University Langone Transplant Institute, New York, NY, USA.ORCID http://orcid.org/0000-0001-8165-525X
Navneet NarulaDepartment of Pathology, New York University Langone Health, New York, NY, USA.
Massimo MangiolaNew York University Langone Transplant Institute, New York, NY, USA.
Elaina P WeldonNew York University Langone Transplant Institute, New York, NY, USA.
Larisa KagermazovaDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.
Les JamesDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Nikki LawsonNew York University Langone Transplant Institute, New York, NY, USA.
Greta L PiperDepartment of Surgery, New York University Langone Health, New York, NY, USA.
Philip M SommerDepartment of Anesthesiology, New York University Langone Health, New York, NY, USA.
Alex ReyentovichDivision of Cardiology, New York University Langone Health, New York, NY, USA.
Daniel BamiraDivision of Cardiology, New York University Langone Health, New York, NY, USA.
Tajinderpal SaraonDivision of Cardiology, New York University Langone Health, New York, NY, USA.
Bernard S KadoshDivision of Cardiology, New York University Langone Health, New York, NY, USA.
Michael DiVitaDivision of Cardiology, New York University Langone Health, New York, NY, USA.ORCID http://orcid.org/0000-0003-4036-2893
Randal I GoldbergDivision of Cardiology, New York University Langone Health, New York, NY, USA.
Syed T HussainDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Justin ChanDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Jennie NgaiDepartment of Anesthesiology, New York University Langone Health, New York, NY, USA.
Thomas JanDepartment of Anesthesiology, New York University Langone Health, New York, NY, USA.
Nicole M AliNew York University Langone Transplant Institute, New York, NY, USA.
Vasishta S TatapudiNew York University Langone Transplant Institute, New York, NY, USA.
Dorry L SegevDepartment of Surgery, New York University Langone Health, New York, NY, USA.
Shivani BisenNew York University Grossman School of Medicine, New York University, New York, NY, USA.ORCID http://orcid.org/0000-0002-2585-0154
Ian S JaffeNew York University Grossman School of Medicine, New York University, New York, NY, USA.ORCID http://orcid.org/0000-0002-7309-308X
Benjamin PiegariColumbia Center for Translational Immunology, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Haley KowalskiNew York University Grossman School of Medicine, New York University, New York, NY, USA.
Maria KokkinakiRevivicor, Inc., Blacksburg, VA, USA.ORCID http://orcid.org/0000-0001-6309-5498
Jeffrey MonahanRevivicor, Inc., Blacksburg, VA, USA.
Lori SorrellsRevivicor, Inc., Blacksburg, VA, USA.
Lars BurdorfRevivicor, Inc., Blacksburg, VA, USA.
Jef D BoekeDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, USA.ORCID http://orcid.org/0000-0001-5322-4946
Harvey PassDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Chandra GoparajuDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Brendan KeatingDepartment of Surgery, University of Pennsylvania, Philadelphia, PA, USA.
David AyaresRevivicor, Inc., Blacksburg, VA, USA.
Marc LorberUnited Therapeutics Corporation, Silver Spring, MD, USA.
Adam GriesemerNew York University Langone Transplant Institute, New York, NY, USA.ORCID http://orcid.org/0000-0003-4894-2024
Sapna A MehtaNew York University Langone Transplant Institute, New York, NY, USA.
Deane E SmithDepartment of Cardiothoracic Surgery, New York University Langone Health, New York, NY, USA.
Robert A MontgomeryNew York University Langone Transplant Institute, New York, NY, USA. Robert.Montgomery@nyulangone.org.
NYU Langone Health · USNew York University · USColumbia University Irving Medical Center · USUnited Therapeutics (United States) · USUniversity of Pennsylvania · US

Funding

The EDRN Mesothelioma Biomarker Discovery LaboratoryU01CA214195 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PASS, HARVEY IRA, YANG, HAINING · 2016 to 2021
$3.5M
NCI NIH HHS U01 CA214195
6 · The paper itself

Abstract

Genetically modified xenografts are one of the most promising solutions to the discrepancy between the numbers of available human organs for transplantation and potential recipients. To date, a porcine heart has been implanted into only one human recipient. Here, using 10-gene-edited pigs, we transplanted porcine hearts into two brain-dead human recipients and monitored xenograft function, hemodynamics and systemic responses over the course of 66 hours. Although both xenografts demonstrated excellent cardiac function immediately after transplantation and continued to function for the duration of the study, cardiac function declined postoperatively in one case, attributed to a size mismatch between the donor pig and the recipient. For both hearts, we confirmed transgene expression and found no evidence of cellular or antibody-mediated rejection, as assessed using histology, flow cytometry and a cytotoxic crossmatch assay. Moreover, we found no evidence of zoonotic transmission from the donor pigs to the human recipients. While substantial additional work will be needed to advance this technology to human trials, these results indicate that pig-to-human heart xenotransplantation can be performed successfully without hyperacute rejection or zoonosis.

Indexed as

AntibodiesGraft RejectionAnimalsAnimals, Genetically ModifiedHeartHeterograftsHumansSwineTransplantation, HeterologousAntibodies

Identifiers

PMID37488288
OpenAlexW4385197460

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.